Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 689 JPY -0.53% Market Closed
Market Cap: 613.5B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Santen Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Interest Income Expense
-ÂĄ8.5B
CAGR 3-Years
-117%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Interest Income Expense
-ÂĄ157.5B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Interest Income Expense
ÂĄ34.8B
CAGR 3-Years
100%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Interest Income Expense
ÂĄ40B
CAGR 3-Years
43%
CAGR 5-Years
30%
CAGR 10-Years
15%
Chugai Pharmaceutical Co Ltd
TSE:4519
Interest Income Expense
ÂĄ39m
CAGR 3-Years
-54%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Interest Income Expense
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%

See Also

What is Santen Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-8.5B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Interest Income Expense amounts to -8.5B JPY.

What is Santen Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-39%

Over the last year, the Interest Income Expense growth was -155%. The average annual Interest Income Expense growth rates for Santen Pharmaceutical Co Ltd have been -117% over the past three years , -39% over the past five years .

Back to Top